Brad DeSilva

About

Brad DeSilva, MD, is a physician and professor in the Department of Otolaryngology at Ohio State University Wexner Medical Center. His expertise is in otolaryngology, with a particular focus on voice, swallowing, sinonasal, and thyroid/parathyroid disorders. He provides both medical and surgical treatment options, working within a multidisciplinary team to develop tailored and targeted treatment plans for his patients. Dr. DeSilva emphasizes helping patients make informed decisions about their care by discussing all available treatment options and their important aspects. His academic and research interests include treatment outcomes of patients with benign vocal fold lesions such as nodules and polyps, laryngeal papilloma, and surgical approaches for cricopharyngeal dysfunction and Zenker’s diverticulum. He also investigates treatment outcomes for vocal fold paralysis and paradoxical vocal fold motion disorder. Dr. DeSilva has contributed to prospective studies evaluating dysphagia outcomes following complex anterior cervical discectomy and fusion surgery, the effectiveness of superior laryngeal nerve blocks, and demographic factors influencing spasmodic dysphonia. His research extends to developing tissue models for laryngeal papilloma and analyzing treatment options for neuropathic cough, aiming to improve patient care and outcomes in otolaryngology.

Research topics

• Medicine
• Internal medicine
• Surgery
• Anesthesia
• Physical therapy
• Pediatrics

Selected publications

• Current and future management of recurrent respiratory papillomatosis

  Laryngoscope Investigative Otolaryngology · 2018-01-14 · 160 citations

  reviewOpen access

  Objectives: Recurrent respiratory papillomatosis (RRP) is a chronic disease of the respiratory tract that occurs in both children and adults. It is caused by the human papillomavirus (HPV), in particular low-risk HPV6 and HPV11, and aggressiveness varies among patients. RRP remains a chronic disease that is difficult to manage. This review provides perspectives on current and future management of RRP. Results: The current standard of care is surgical excision, with adjuvant therapies as needed.…

  PublisherOA PDFDOI

• Risk Factors for Posttracheostomy Tracheal Stenosis

  Otolaryngology · 2018-08-21 · 94 citations

  article

  Objective To determine the incidence of posttracheostomy tracheal stenosis and to investigate variables related to the patient, hospitalization, or operation that may affect stenosis rates. Study Design A combined retrospective cohort and case‐control study. Setting Tertiary care academic medical center. Subjects and Methods A total of 1656 patients who underwent tracheostomy at a tertiary care medical center from January 2011 to November 2016 were reviewed for evidence of subsequent tracheal st…

  PublisherDOI

• Does treatment of paradoxical vocal fold movement disorder decrease asthma medication use?

  The Laryngoscope · 2016-11-15 · 40 citations

  article

  OBJECTIVES/HYPOTHESIS: To determine whether diagnosis and treatment of paradoxical vocal fold movement disorder (PVFMD) leads to decreased asthma medication use. Secondary objectives include determining initial rate of asthma medication use, characterizing symptom improvement, and correlating with pulmonary function testing (PFT). STUDY DESIGN: Prospective observational study. METHODS: Patients newly diagnosed with PVFMD at a single institution were recruited to participate. Medication questionn…

  PublisherDOI

• Immunological tolerance of low-risk HPV in recurrent respiratory papillomatosis

  Clinical & Experimental Immunology · 2019-10-19 · 35 citations

  reviewOpen access

  Summary Recurrent respiratory papillomatosis (RRP) is characterized by benign exophytic lesions of the respiratory tract caused by the human papillomavirus (HPV), in particular low-risk HPV6 and HPV11. Aggressiveness varies greatly among patients. Surgical excision is the current standard of care for RRP, with adjuvant therapy used when surgery cannot control disease recurrence. Numerous adjuvant therapies have been used to control RRP with some success, but none are curative. Current literature…

  PublisherOA PDFDOI

• Vocal fold botulinum toxin injection for refractory paradoxical vocal fold motion disorder

  The Laryngoscope · 2018-12-13 · 27 citations

  article1st authorCorresponding

  OBJECTIVE: Demonstrate efficacy of vocal fold botulinum toxin injection for treatment of refractory paradoxical vocal fold motion disorder (PVFMD). METHODS: A retrospective review was completed of patients diagnosed with PVFMD who underwent vocal fold botulinum toxin injection for dyspnea symptoms that persisted despite laryngeal control therapy, medical management, and biofeedback therapy. Outcomes measured included overall improvement and resolution of dyspnea symptoms, number of botulinum tox…

  PublisherDOI

Frequent coauthors

• Laura Matrka

  The Ohio State University

  22 shared

• L. Arick Forrest

  The Ohio State University Wexner Medical Center

  13 shared

• Ryan Ivancic

  11 shared

• Peter C. Belafsky

  6 shared

• Milan R. Amin

  New York University

  6 shared

• Brandon Kim

  Sibel (United States)

  6 shared

• Lyndsay L. Madden

  Wake Forest University

  5 shared

• Jacqui Allen

  University of Auckland

  5 shared

Awards & honors

• Faculty Educator of the Year Award, 2010
• Rated in the top 10 percent of physicians in the nation for…
• Gahanna Lincoln High School Hall of Fame Inductee, 2012
• Named to Castle Connolly's Regional Top Doctors list

Similar researchers at Ohio State University

• Amit Agrawalh-48
• Oliver Adunkah-47
• Christopher Brooksh-34